Last reviewed · How we verify

Pregnyl: Human chorionic gonadotrophin — Competitive Intelligence Brief

Pregnyl: Human chorionic gonadotrophin (Pregnyl: Human chorionic gonadotrophin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotrophin. Area: Reproductive/Fertility.

marketed Gonadotrophin Luteinizing hormone receptor (LH receptor) Reproductive/Fertility Small molecule Live · refreshed every 30 min

Target snapshot

Pregnyl: Human chorionic gonadotrophin (Pregnyl: Human chorionic gonadotrophin) — Genuine Research Center, Egypt. Human chorionic gonadotrophin (hCG) mimics luteinizing hormone to stimulate testosterone production in males and ovulation in females.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Pregnyl: Human chorionic gonadotrophin TARGET Pregnyl: Human chorionic gonadotrophin Genuine Research Center, Egypt marketed Gonadotrophin Luteinizing hormone receptor (LH receptor)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotrophin class)

  1. Genuine Research Center, Egypt · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Pregnyl: Human chorionic gonadotrophin — Competitive Intelligence Brief. https://druglandscape.com/ci/pregnyl-human-chorionic-gonadotrophin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: